Assessment of premature menopause on the sexual function and quality of life in women

Abstract Introduction Premature Ovarian Insufficiency (POI) is characterized by ending menstruation in women under 40 years of age. It has a significant effect on women's sexuality and mental health and quality of life. This study aimed to evaluate the sexual function and quality of life of premature menopausal women. Methods This study was a case-control study on 132 people (66 women with a diagnosis of POF and 66 women of reproductive age with normal ovarian function) who were matched in terms of the age, presenting to Women's Clinic in Jahrom in 2019. The WHOQOL-BREF questionnaire and the Female Sexual Function Index (FSFI) questionnaire were used to collect data. p < .05 was considered statistically significant. Results The mean score of sexual function in premature menopausal women was 21.35 ± 4.82 and in non-menopausal women was 25.4 ± 6.61 (OR = 0.11, 95% CI = 0.04–0.28). All areas of sexual function; desires disorder (OR = 0.21 95% CI = 0.07–0.56), Arousal disorder(OR = 0.28, 95% CI = 0.08–0.93), orgasm disorder (OR = 0.36 95% CI = 0.16–0.80), lubrication disorder (OR = 0.21 95% CI= 0.05–0.78), satisfaction disorder (OR = 0.11, 95% CI = 0.04–0.28) and quality of life domains: physical health (OR = 0.4 95%CI = 0.06–0.3), mental health (OR = 0.28 95% CI = 0.06–0.1), environmental health (OR = 0.22 95%CI = 0.04–0.6) and social health (OR = 0.28 95%CI = 0.01–0.2) saw a decrease in the premature menopausal women group compared to the control group. Conclusion The results demonstrated that premature menopausal women are found to be weaker than the control group in all areas of sexual function and quality of life. Among the areas of sexual function, such as libido, arousal, satisfaction, and pain have the most impact on quality of life. Therefore, based on the results from improving sexual function, this issue can improve the quality of life.

[1]  F. Ramezani Tehrani,et al.  An exploration of factors affecting the quality of life of women with primary ovarian insufficiency: a qualitative study , 2020, BMC Women's Health.

[2]  Y. Liu,et al.  Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis , 2019, Quality of Life Research.

[3]  R. Słopień.  Mood disorders in women with premature ovarian insufficiency , 2018, Przeglad menopauzalny = Menopause review.

[4]  S. Vitale,et al.  Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study , 2018, Przeglad menopauzalny = Menopause review.

[5]  C. Benetti-Pinto,et al.  Influence of Sexual Function on the Social Relations and Quality of Life of Women with Premature Ovarian Insufficiency , 2018, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.

[6]  R. Cífková,et al.  ESHRE Guideline: management of women with premature ovarian insufficiency. , 2016, Human Reproduction.

[7]  S. Caruso,et al.  Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel , 2016, Menopause.

[8]  Jianfeng Xu,et al.  Risks associated with premature ovarian failure in Han Chinese women. , 2015, Reproductive biomedicine online.

[9]  N. Panay,et al.  Current Concepts in Premature Ovarian Insufficiency , 2015, Women's health.

[10]  C. Benetti-Pinto,et al.  Role of the different sexuality domains on the sexual function of women with premature ovarian failure. , 2015, The journal of sexual medicine.

[11]  E. Mann,et al.  Psychosocial adjustment in women with premature menopause: a cross-sectional survey , 2012, Climacteric : the journal of the International Menopause Society.

[12]  C. Benetti-Pinto,et al.  Quality of life in women with premature ovarian failure , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[13]  C. Benetti-Pinto,et al.  Sexual function of women with premature ovarian failure , 2011, Menopause.

[14]  D. Rubinow,et al.  Depression in women with spontaneous 46, XX primary ovarian insufficiency. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  A. Graziottin.  Menopause and sexuality: key issues in premature menopause and beyond , 2010, Annals of the New York Academy of Sciences.

[16]  S. Weisbord,et al.  Sexual function in women receiving maintenance dialysis , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[17]  C. Lambalk,et al.  Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure , 2008, Menopause.

[18]  A. Yıldırım,et al.  Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients , 2008, International Urology and Nephrology.

[19]  R. Crosby,et al.  Refining self-reported condom use among young men at risk of HIV acquisition. , 2007, Sexual health.

[20]  A. Graziottin.  Prevalence and evaluation of sexual health problems--HSDD in Europe. , 2007, The journal of sexual medicine.

[21]  S. Khosla,et al.  Androgen therapy in women: an Endocrine Society Clinical Practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  N. Watts,et al.  Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial , 2006, Menopause.

[23]  H. Burger,et al.  Testosterone and Libido in Surgically and Naturally Menopausal Women , 2006, Women's health.

[24]  N. Keiding,et al.  The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. , 2006, Maturitas.

[25]  M. Seif,et al.  Testosterone for peri- and postmenopausal women. , 2005, The Cochrane database of systematic reviews.

[26]  I. Goldstein,et al.  Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. , 2005, The journal of sexual medicine.

[27]  G. Braunstein,et al.  Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  Candace S. Brown,et al.  Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. , 2005, Obstetrics and gynecology.

[29]  A. Graziottin,et al.  Sexual dysfunction in women with premature menopause , 2004, Menopause.

[30]  Orman,et al.  Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. , 2000, The New England journal of medicine.

[31]  G. Conway,et al.  Premature menopause and psychological well-being , 2000, Journal of psychosomatic obstetrics and gynaecology.

[32]  A. Obruca,et al.  Premature ovarian failure: etiology and prospects , 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[33]  D L Patrick,et al.  Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. , 2000, Journal of clinical epidemiology.

[34]  Candace S. Brown,et al.  The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. , 2000, Journal of sex & marital therapy.

[35]  G. Wagner,et al.  Estrogen deprivation and vaginal function in postmenopausal women. , 1982, JAMA.